Futura Medical
Management update details degree of 2021 progressFutura Medical
A year of delivery, with key milestones achievedFutura Medical
Raising £12m through £10m placing and £2m retail offerFutura Medical
MED3000 receives CE Mark as a Class II(b) deviceFutura Medical
FY21 is set to be a year of executionFutura Medical
EU Notified Body recommends MED3000 approvalFutura Medical
Commercialisation deal for China and SE AsiaFutura Medical
MED3000: FDA details the scope of confirmatory studyFutura Medical
MED3000 on course for OTC approval in Europe and USFutura Medical
FDA green lights MED3000 for OTC approval